
Glirega M 2mg/500mg Tablet SR
Marketer
Curega Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glirega M 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.
Uses of Glirega M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glirega M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Take Glirega M 2mg/500mg Extended-Release Tablets with a meal.
Common Side effects of Glirega M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glirega M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glirega M 2mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Consume this extended-release tablet with a meal.
How Glirega M 2mg/500mg Tablet SR works:
Glireg-M 2mg/500mg extended-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glirega M 2mg/500mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glirega M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Glirega M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glirega M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glirega M 2mg/500mg SR tablets. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glirega M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glirega M 2mg/500mg Tablet SR :
Should you forget a Glirega M 2mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glirega M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
